Literature DB >> 8438648

Polycystic kidney disease: hereditary and acquired.

J J Grantham1.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8438648

Source DB:  PubMed          Journal:  Adv Intern Med        ISSN: 0065-2822


× No keyword cloud information.
  11 in total

1.  Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.

Authors:  Marusia Lilova; Bernard S Kaplan; Kevin E C Meyers
Journal:  Pediatr Nephrol       Date:  2002-11-26       Impact factor: 3.714

Review 2.  Transient receptor potential channelopathies.

Authors:  Bernd Nilius; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2010-02-04       Impact factor: 3.657

3.  Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.

Authors:  W G Richards; W E Sweeney; B K Yoder; J E Wilkinson; R P Woychik; E D Avner
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Polycystin 1 is required for the structural integrity of blood vessels.

Authors:  K Kim; I Drummond; O Ibraghimov-Beskrovnaya; K Klinger; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

5.  Isolation and characterization of liver epithelial cell lines from wild-type and mutant TgN737Rpw mice.

Authors:  W G Richards; B K Yoder; R J Isfort; P G Detilleux; C Foster; N Neilsen; R P Woychik; J E Wilkinson
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

6.  Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1.

Authors:  R Palsson; C P Sharma; K Kim; M McLaughlin; D Brown; M A Arnaout
Journal:  Mol Med       Date:  1996-11       Impact factor: 6.354

7.  Oval cell proliferation associated with the murine insertional mutation TgN737Rpw.

Authors:  W G Richards; B K Yoder; R J Isfort; P G Detilleux; C Foster; N Neilsen; R P Woychik; J E Wilkinson
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

8.  Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development.

Authors:  Shengli Cai; Jeffrey I Everitt; Hiroyuki Kugo; Jennifer Cook; Elena Kleymenova; Cheryl Lyn Walker
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 9.  The transient receptor potential family of ion channels.

Authors:  Bernd Nilius; Grzegorz Owsianik
Journal:  Genome Biol       Date:  2011-03-17       Impact factor: 13.583

10.  Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment.

Authors:  Christian R Halvorson; Matthew S Bremmer; Stephen C Jacobs
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.